Literature DB >> 15887624

Strain variability in Zucker rats affects their response to oral oleoyl-estrone.

M Díaz-Silva1, M M Grasa, M Blay, J A Fernández-López, X Remesar, M Alemany.   

Abstract

There is a considerable variability in the responses of Zucker fa/fa rats in metabolic studies, which could not be solely attributed to the leprfa mutation. In order to fathom the extent of this variability, we compared the response to oleoyl-estrone (OE), a powerful lipid-mobilising agent, of two strains of Zucker lean and obese rats: Harlan (H) and Charles River (CR). Rats were given an oral gavage of 10 micromol/day/kg of OE in sunflower oil, and were compared with oil-receiving controls. Body composition, energy and water balances, and plasma parameters were studied after 10 days of treatment. H rats showed a higher water turnover than CR rats; OE treatment reduced water intake, partly compensated by metabolic water, and decreased stool water. H rats accrued more cholesterol than CR animals, which showed higher cholesterolaemia. OE facilitated cholesterol disposal in lean (CR and H) and H obese rats. CR rats had higher body and liver lipids than H animals. No differences in energy balance were found. Insulin decrease following OE treatment was greater in lean CR than in H rats, but this trend was reversed in the obese rats, lacking effective responses to leptin. The red cell glucose compartment was smaller in H than in CR rats; the higher insulin levels in H rats may be partly responsible for that difference. Obese H maintained glycaemia (and liver glycogen) with higher insulin levels than CR animals. The extent to which the leprfa mutation affects the responses of Zucker fa/fa rats could not be singled out unless the metabolic environment of the batch used is known. This variability must be taken into account when developing a metabolic or hormonal study in which this model of obesity is used.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15887624

Source DB:  PubMed          Journal:  Diabetes Nutr Metab        ISSN: 0394-3402


  2 in total

1.  Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.

Authors:  Lucia Mráziková; Silvie Hojná; Andrea Pačesová; Lucie Hrubá; Veronika Strnadová; Barbora Neprašová; Blanka Železná; Jaroslav Kuneš; Lenka Maletínská
Journal:  Nutr Diabetes       Date:  2022-05-19       Impact factor: 4.725

2.  The conjugated linoleic acid ester of estrone induces the mobilisation of fat in male Wistar rats.

Authors:  M M Romero; M Esteve; J A Fernández-López; M Alemany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-27       Impact factor: 3.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.